24HourWire
News from all angles
MedPage Today
Center
Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement
(MedPage Today) -- In patients treated with resmetirom (Rezdiffra), early responses in blood and imaging biomarkers were associated with resolution of metabolic dysfunction-associated steatohepatitis…